Skip to main page content
Access keys NCBI Homepage MyNCBI Homepage Main Content Main Navigation

Search Page

My NCBI Filters
Results by year

Table representation of search results timeline featuring number of search results per year.

Year Number of Results
1992 1
2000 1
2001 1
2003 2
2004 2
2005 3
2006 3
2007 1
2008 5
2010 5
2011 3
2012 5
2013 3
2014 3
2015 2
2016 1
2017 1
2018 2
2021 0
Text availability
Article attribute
Article type
Publication date

Search Results

40 results
Results by year
Filters applied: . Clear all
Page 1
Homologous Recombination Deficiency (HRD) Score Predicts Response to Platinum-Containing Neoadjuvant Chemotherapy in Patients with Triple-Negative Breast Cancer.
Telli ML, Timms KM, Reid J, Hennessy B, Mills GB, Jensen KC, Szallasi Z, Barry WT, Winer EP, Tung NM, Isakoff SJ, Ryan PD, Greene-Colozzi A, Gutin A, Sangale Z, Iliev D, Neff C, Abkevich V, Jones JT, Lanchbury JS, Hartman AR, Garber JE, Ford JM, Silver DP, Richardson AL. Telli ML, et al. Among authors: ryan pd. Clin Cancer Res. 2016 Aug 1;22(15):3764-73. doi: 10.1158/1078-0432.CCR-15-2477. Epub 2016 Mar 8. Clin Cancer Res. 2016. PMID: 26957554 Free PMC article. Clinical Trial.
Telomeric allelic imbalance indicates defective DNA repair and sensitivity to DNA-damaging agents.
Birkbak NJ, Wang ZC, Kim JY, Eklund AC, Li Q, Tian R, Bowman-Colin C, Li Y, Greene-Colozzi A, Iglehart JD, Tung N, Ryan PD, Garber JE, Silver DP, Szallasi Z, Richardson AL. Birkbak NJ, et al. Among authors: ryan pd. Cancer Discov. 2012 Apr;2(4):366-375. doi: 10.1158/2159-8290.CD-11-0206. Epub 2012 Mar 22. Cancer Discov. 2012. PMID: 22576213 Free PMC article.
Efficacy of neoadjuvant Cisplatin in triple-negative breast cancer.
Silver DP, Richardson AL, Eklund AC, Wang ZC, Szallasi Z, Li Q, Juul N, Leong CO, Calogrias D, Buraimoh A, Fatima A, Gelman RS, Ryan PD, Tung NM, De Nicolo A, Ganesan S, Miron A, Colin C, Sgroi DC, Ellisen LW, Winer EP, Garber JE. Silver DP, et al. Among authors: ryan pd. J Clin Oncol. 2010 Mar 1;28(7):1145-53. doi: 10.1200/JCO.2009.22.4725. Epub 2010 Jan 25. J Clin Oncol. 2010. PMID: 20100965 Free PMC article.
TBCRC009: A Multicenter Phase II Clinical Trial of Platinum Monotherapy With Biomarker Assessment in Metastatic Triple-Negative Breast Cancer.
Isakoff SJ, Mayer EL, He L, Traina TA, Carey LA, Krag KJ, Rugo HS, Liu MC, Stearns V, Come SE, Timms KM, Hartman AR, Borger DR, Finkelstein DM, Garber JE, Ryan PD, Winer EP, Goss PE, Ellisen LW. Isakoff SJ, et al. Among authors: ryan pd. J Clin Oncol. 2015 Jun 10;33(17):1902-9. doi: 10.1200/JCO.2014.57.6660. Epub 2015 Apr 6. J Clin Oncol. 2015. PMID: 25847936 Free PMC article. Clinical Trial.
On receptor inhibitors and chemotherapy.
Ryan PD, Chabner BA. Ryan PD, et al. Clin Cancer Res. 2000 Dec;6(12):4607-9. Clin Cancer Res. 2000. PMID: 11156209 Free article. Review. No abstract available.
Faciocutaneous cancer syndromes: spot the diagnosis.
Morrison PJ, Ryan PD. Morrison PJ, et al. Among authors: ryan pd. Oncologist. 2012;17(7):886-7. doi: 10.1634/theoncologist.2012-0171. Epub 2012 Jun 15. Oncologist. 2012. PMID: 22707508 Free PMC article.
Which individuals undergoing BRACAnalysis need BART testing?
Shannon KM, Rodgers LH, Chan-Smutko G, Patel D, Gabree M, Ryan PD. Shannon KM, et al. Among authors: ryan pd. Cancer Genet. 2011 Aug;204(8):416-22. doi: 10.1016/j.cancergen.2011.07.005. Cancer Genet. 2011. PMID: 21962891
40 results
You have reached the last page of results. A maximum of 10,000 results are available.
Jump to page